New drug shows promise for slowing kidney damage
NCT ID NCT05016323
Summary
This study tested whether HR19042 capsules could help people with IgA nephropathy, a kidney disease where protein leaks into urine. Researchers compared the capsules against placebo pills in 316 adults with confirmed kidney damage. The main goal was to see if the treatment could reduce protein in urine, which indicates better kidney protection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IGA NEPHROPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
NanFang Hospital of Southern Medical University
Guangzhou, Guangdong, 510515, China
Conditions
Explore the condition pages connected to this study.